Award
National Institute of General Medical Sciences 5R44GM150317-03
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
Recipient
INTEGRAL MOLECULAR
Award Amount
$631,033.00
Ceiling
$631,033.00
Awarded
July 30, 2026
Identifier
5R44GM150317-03
NIH awarded INTEGRAL MOLECULAR $631,033 to develop high-quality monoclonal antibodies targeting understudied membrane proteins such as GPCRs and ion channels, supporting biomedical research and potential therapeutics.
Description
This project aims to develop monoclonal antibodies (MAbs) against membrane proteins, specifically GPCRs and ion channels, as part of NIH's Illuminating the Druggable Genome (IDG) initiative to explore understudied druggable targets. The project duration is approximately 4.75 years, funded by NIH's National Institute of General Medical Sciences (NIGMS).